Teva has sold off remaining women’s health assets
Israeli pharma group, Teva Pharmaceutical Industries Ltd, has published that it has entered into two agreements to sell off its remaining women’s health assets for $1.38 billion. The announcement comes after the sale of Paragard, which combined with the proceeds from its latest sale, totals $2.48 billion and will go towards paying off its debts.…